About Consern Pharma Limited
Data last updated:
Consern Pharma Limited is a public limited company based in Ludhiana, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 October 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2001PLC024715. Its GSTIN is 03AABCC7730R1ZF (Punjab). The company holds 10 GST registrations, all of them active.
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹30.77 Lakh. It was formerly known as Consern Pharma Private Limited. It is led by directors including Kuljive Mahajan (Managing Director) and Seema Mahajan (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 308 – C Bhai Randhir Singh Nagar, Ludhiana, Punjab, India – 141012.
As per the financials filed for FY 2025, the company reported a revenue of ₹100.37 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹9.64 Cr (net margin 9.6%) and EBITDA of ₹15.1 Cr (EBITDA margin 15%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 17% over five years.
The company has about 504 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Consern and Consern Pharma. As per MCA filings, the company has open charges of ₹8 Cr and satisfied charges of ₹16.69 Cr on record. Court records list 60 cases involving the company, including 46 filed by the company and 14 filed against it; 15 cases are pending. The company has 13 deals on record (12 secondary share transfers, 1 funding round), with disclosed funding of ₹14.7 Lakh; the latest was in March 2019. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Nabros Pharma Private Limited with revenue of ₹101.03 Cr. The company has 4 MSME Form 1 returns on record between 2019 and 2020, listing 369 overdue payments to 18 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website consernpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address308 – C Bhai Randhir Singh Nagar, Ludhiana, Punjab, India – 141012
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Consern Pharma Limited
The main business activity of Consern Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Consern Pharma Limited FY 2024 filings available
Consern Pharma Limited reported revenue of ₹100.37 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Consern Pharma Limited
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Consern Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹15.1 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹9.64 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Consern Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Consern Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Consern Pharma Limited
Consern Pharma Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nabros Pharma Private Limited | ₹101.03 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Ahmedabad, Gujarat, India |
| Instapill Private Limited | ₹100.92 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Bangalore, Karnataka, India |
| Sotac Pharmaceuticals Limited | ₹100.88 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Sanand, Gujarat, India |
| Lake Chemicals Private Limited | ₹100.59 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Bangalore, Karnataka, India |
| Credo Life Sciences Private Limited | ₹100.47 Cr (FY 2024) | •••• | •••• | 22.0% | •••• | Hyderabad, Telangana, India |
| Consern Pharma Limited this company | ₹100.37 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Ludhiana, Punjab, India |
| Addii Biotech Private Limited | ₹100.32 Cr (FY 2025) | •••• | •••• | 59.0% | •••• | Chandigarh, India |
| Medibios Laboratories Limited | ₹100.12 Cr (FY 2023) | •••• | •••• | -2.0% | •••• | |
| Angel Biogenics Private Limited | ₹99.49 Cr (FY 2025) | •••• | •••• | -22.0% | •••• | Rajkot, Gujarat, India |
| Synokem Lifesciences Private Limited | ₹99.46 Cr (FY 2025) | •••• | •••• | 108.0% | •••• | New Delhi, Delhi, India |
| Shri Nivas (Gujarat) Laboratories Pvt Ltd | ₹98.85 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Patna, Bihar, India |
Peers are the five companies nearest above and the five nearest below Consern Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Consern Pharma Limited
Consern Pharma Limited is audited by DASS KHANNA & CO for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DASS KHANNA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Consern Pharma Limited
Consern Pharma has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seema Mahajan | Whole-Time Director | 17 Oct 2001 | 25 Years 0 Months | Current |
| Kuljive Mahajan | Managing Director | 01 Apr 2004 | 22 Years 6 Months | Current |
| Riaz K Mahajan | Additional Director | 01 Jun 2025 | 1 Years 4 Months | Current |
| Atul Bhatara | Director | 01 Oct 2024 | 2 Years 0 Months | Current |
| Suresh Goel Also directs: Nirman Fincap Private Limited, Lumikei Med Private Limited | Additional Director | 01 Sep 2025 | 1 Years 1 Months | Current |
Ownership and Shareholding of Consern Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Consern Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jan 2025 | Others | ₹8 Cr | Open |
| 26 Feb 2020 | Indian Overseas Bank | ₹7.96 Cr | Satisfied |
| 22 Apr 2019 | Others | ₹50 Lakh | Satisfied |
| 07 Oct 2017 | Hdfc Bank Limited | ₹6.7 Cr | Satisfied |
| 03 Jul 2010 | Indian Overseas Bank | ₹40 Lakh | Satisfied |
Total charge records: 7 View all charges
Deals & Funding of Consern Pharma Limited
Consern Pharma Limited has 13 deals on record (12 secondary share transfers, 1 funding round), with disclosed funding of ₹14.7 Lakh; the latest was in March 2019.
Deals on record (5 of 13)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
| Nov 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Oct 2016 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
| Sep 2016 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Jul 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Full deal history
All 13 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Consern Pharma Limited
Consern Pharma Limited has 60 court cases on record: 46 filed by Consern Pharma, 14 filed against it. 15 cases are pending and 45 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 51 | 7 | 11 |
| High courts | 9 | 7 | 4 |
Cases on record (5 of 60)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Sun Pharma Laboratories Limited | Pending |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed against the company by Sun Pharma Laboratories Limited | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Ikon Pharmachem Private Limited | Pending |
| District court, South East, Delhi | Commercial suit | Filed by the company against Concertina Pharma Private Limited | Pending |
| Calcutta High Court | Court case (IP-COM) | Filed against the company by A.N.Pharmacia Laboratories Pvt Ltd. | Disposed |
Full case history
All 60 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Consern Pharma Limited
Consern Pharma Limited has 4 MSME Form 1 returns on record between 2019 and 2020, listing 369 overdue payments to 18 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 18)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Resonance Laboratories Private Limited | •••• | •••• | •••• |
| Elnova Pharma | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Roaq Chemicals Pvt. Ltd. | •••• | •••• | •••• |
| Bajaj Healthcare Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 4 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Consern Pharma Limited
Consern Pharma operates two associated brands: Consern and Consern Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Consern is an R&D company focused on manufacturing drugs for various therapeutic areas. | consern.in | |
| Pharmaceutical manufacturing and research in Neuro-Psychiatry and other healthcare segments. | consernpharma.com |
Employees and EPFO Compliance at Consern Pharma Limited
Consern Pharma Limited has a workforce of 504 employees as of Sep 25, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Consern Pharma Limited
Consern Pharma has one previous CIN (Corporate Identification Number): U24232PB2001PTC024715. The current CIN is U24232PB2001PLC024715, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232PB2001PLC024715 | Current |
| U24232PB2001PTC024715 | Previous |
Recent Activity on Consern Pharma Limited
Consern Pharma Limited has 11 board changes on record since 2001: 7 appointments and 4 cessations. The latest: Suresh Goel was appointed as Additional Director on 01 Sep 2025.
19 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Consern Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Consern Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Consern Pharma Limited
Consern Pharma has 10 GST registrations: 10 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AABCC7730R1ZF | Punjab | Active | 01 Jul 2017 |
| 10AABCC7730R1ZK | Bihar | Active | 01 Jul 2017 |
| 08AABCC7730R1Z5 | Rajasthan | Active | 19 Feb 2021 |
| 09AABCC7730R1Z3 | Uttar Pradesh | Active | 04 May 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Consern Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Consern Pharma Limited
Consern Pharma is an active public limited company based in Ludhiana, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 October 2001 (25+ years old) and is registered under CIN U24232PB2001PLC024715.
Consern Pharma reported revenue of ₹100.37 Cr for FY 2025 (down 2% YoY).
Consern Pharma has 5 current directors:
- Kuljive Mahajan - Managing Director
- Seema Mahajan - Whole-Time Director
- Riaz K Mahajan - Additional Director
- Atul Bhatara - Director
- Suresh Goel - Additional Director
Consern Pharma reported a net profit of ₹9.64 Cr (net margin 9.6%) and EBITDA of ₹15.1 Cr (EBITDA margin 15%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Consern Pharma is 19% over three years and 17% over five years. In the latest year (FY 2025) revenue fell 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Consern Pharma is 03AABCC7730R1ZF, registered in Punjab. The company has 10 GST registrations in all, of which 10 are active. Other active GSTINs include 10AABCC7730R1ZK (Bihar), 08AABCC7730R1Z5 (Rajasthan), 09AABCC7730R1Z3 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Consern Pharma is U24232PB2001PLC024715. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Consern Pharma has 60 court cases on record: 46 filed by the company and 14 filed against it. 15 are pending. Most are in the district courts.
Consern Pharma was incorporated on 17 October 2001, making it 25+ years old. It is registered with the Registrar of Companies, Chandigarh.
Consern Pharma has 13 deals on record (12 secondary share transfers, 1 funding round), with disclosed funding of ₹14.7 Lakh; the latest was in March 2019.
The peers of Consern Pharma by revenue are Nabros Pharma Private Limited, Instapill Private Limited, Sotac Pharmaceuticals Limited, Lake Chemicals Private Limited, Credo Life Sciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Suresh Goel was appointed as Additional Director on 01 Sep 2025. Riaz K Mahajan was appointed as Additional Director on 01 Jun 2025. Atul Bhatara was appointed as Director on 01 Oct 2024. Consern Pharma has 11 board changes on record in total.